Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Receipt of deferred consideration

25th Nov 2022 07:00

RNS Number : 5537H

Omega Diagnostics Group PLC

25 November 2022

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Receipt of deferred consideration

Omega (AIM: ODX), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that it has now received the £4.0m of deferred consideration relating to the sale of the CD4 business.

Accordingly, as of close of business on 24 November 2022, Omega held cash balances of £6.5m.

The information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.

Contacts:

Omega Diagnostics Group PLC	www.omegadiagnostics.com
Jag Grewal, Chief Executive	via Walbrook PR
Chris Lea, Chief Financial Officer

finnCap Ltd	Tel: 020 7220 0500
Geoff Nash/Edward Whiley (Corporate Finance)
Alice Lane/ Harriet Ward (ECM)

Walbrook PR Limited	Tel: 020 7933 8780 or [email protected]
Paul McManus / Sam Allen	Mob: 07980 541 893 / Mob: 07502 558 258

About Omega Diagnostics Group PLC

Omega (AIM: ODX) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

www.omegadx.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCFEFFMLEESEIF

Related Shares:

FTSE 100 Latest

Value8,809.74

Change53.53